edited by H. Hugh Fudenberg, 212 pp, with illus, $29.50, New York,Plenum Press, 1983.
This article is only available in the PDF format. Download the PDF to view the article, as well as its associated figures and tables.
This is one of those books where a prospective editor, having persuaded a publisher that an audience awaits, invites or reprints a selection of articles around a general topic. The 11 chapters of this volume, some reprinted from major medical journals, appear without editorial comment. They cover a wide range—from a speculative essay comparing creativity in research and art, to the details of how Baltimore City Hospital pays its medical faculty.
A technical article on prenatal diagnosis of the genetic disorders of hemoglobin is followed by a Genex Corporation report on the commercial potentials of recombinant DNA and by an account of how private foundations work, and how one of them, The Robert Wood Johnson Foundation, has decided its priorities (which, incidentally, do not include biomedical research). Additional chapters explain the research interests of the World Health Organization, how the pharmaceutical industry's approach to research differs from that of the
Madison DL. Biomedical Institutions, Biomedical Funding, and Public Policy. JAMA. 1985;253(4):581-582. doi:10.1001/jama.1985.03350280141046